EUVIMEDEUVIMED entdecken
Crossref

Predictors of Thyroid Malignancy in Graves' Disease: The Role of Body Mass Index in a Surgical Cohort

Ozan Caliskan iD, Mehmet Taner Unlu iD, Isik Cetinoglu iD, Ahmet Faruk Yener iD, Nurcihan Aygun iD, Mehmet Uludag iD

The Laryngoscope · 2026

DOI: 10.1002/lary.70862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Ozan Caliskan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, University of Health Sciences Turkey, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Graves Disease, Body Mass Index, Thyroid Neoplasms, Thyroid Cancer, Papillary. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The incidence of thyroid carcinoma in patients with Graves' disease (GD) has increased, with reported rates ranging from 1% to 21%. While thyroid nodules are a well‐established risk factor, the role of body mass index (BMI) in predicting malignancy in GD remains unclear. This study aimed to evaluate the prevalence of thyroid cancer in GD and identify independent predictors to improve preoperative risk stratification.

Methods

We retrospectively analyzed 206 consecutive patients who underwent thyroidectomy for GD between 2016 and 2024. Demographic characteristics, preoperative biochemical parameters, and postoperative histopathological findings were reviewed. Patients were classified as malignant ( n = 42) or benign ( n = 164). All malignancies were papillary thyroid carcinoma.

Results

The mean age was 42.3 ± 13.2 years, and 74.8% were female. Age was not associated with malignancy. Female sex was more prevalent in the malignant group (88.1% vs. 71.3%; p = 0.026). Patients with malignancy had significantly higher BMI (28.1 ± 4.2 vs. 25.5 ± 4.3 kg/m 2 ; p = 0.001) and a higher rate of thyroid nodules (66.7% vs. 31.1%; p < 0.001). Biochemical parameters were not predictive. Multivariable analysis identified female sex (OR = 2.90, p = 0.045), thyroid nodules (OR = 3.27, p = 0.002), and BMI (OR = 1.13 per kg/m 2 , p = 0.005) as independent predictors. BMI alone showed moderate discrimination (AUC = 0.67).

Conclusion

Higher BMI is independently associated with thyroid malignancy in GD and may serve as a clinically relevant adjunctive risk marker. When combined with thyroid nodules and sex, BMI may enhance preoperative risk stratification and support more individualized surgical decision‐making in patients with GD. Level of Evidence 3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseBody Mass IndexThyroid NeoplasmsThyroid Cancer, PapillaryHumansFemaleRetrospective StudiesAdultThyroidectomyMaleMiddle AgedRisk FactorsPrevalenceRisk Assessment

Stichwörter der Autor:innen

Graves' diseasebody mass indexpapillary thyroid carcinomarisk factorsthyroid cancerthyroid nodules

Autor:innen und Institutionen

  • Department of General Surgery, University of Health Sciences Turkey, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey.

ORCID-Profile: Ozan Caliskan, Mehmet Taner Unlu, Isik Cetinoglu, Ahmet Faruk Yener, Nurcihan Aygun, Mehmet Uludag

Zitieren

APA

Caliskan, O., Unlu, M. T., Cetinoglu, I., Yener, A. F., Aygun, N., & Uludag, M. (2026). Predictors of Thyroid Malignancy in Graves' Disease: The Role of Body Mass Index in a Surgical Cohort. The Laryngoscope. https://doi.org/10.1002/lary.70862

Vancouver

Caliskan O, Unlu MT, Cetinoglu I, Yener AF, Aygun N, Uludag M. Predictors of Thyroid Malignancy in Graves' Disease: The Role of Body Mass Index in a Surgical Cohort. The Laryngoscope. 2026. doi:10.1002/lary.70862

BibTeX
@article{Caliskan2026,
  author = {Caliskan, Ozan and Unlu, Mehmet Taner and Cetinoglu, Isik and Yener, Ahmet Faruk and Aygun, Nurcihan and Uludag, Mehmet},
  title = {Predictors of Thyroid Malignancy in Graves' Disease: The Role of Body Mass Index in a Surgical Cohort},
  journal = {The Laryngoscope},
  year = {2026},
  doi = {10.1002/lary.70862}
}
Kostenlos starten →